CA
CRMD icon

Cliff Asness’s CorMedix CRMD Stock Holding History

Cliff Asness’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
151,435
-83,249
-35% -$658K ﹤0.01% 2909
2026
Q1 		$1.59M Buy
234,684
+80,458
+52% +$595K ﹤0.01% 2498
2025
Q4 		$1.79M Buy
154,226
+78,534
+104% +$868K ﹤0.01% 2191
2025
Q3 		$880K Sell
75,692
-22,980
-23% -$278K ﹤0.01% 2508
2025
Q2 		$1.22M Buy
98,672
+84,204
+582% +$930K ﹤0.01% 2083
2025
Q1 		$89.1K Sell
14,468
-2,497
-15% -$25.8K ﹤0.01% 3028
2024
Q4 		$137K Buy
+16,965
New +$169K ﹤0.01% 2730
2024
Q3 		– Sell
-11,189
Closed -$48.4K – 2781
2024
Q2 		$48.4K Sell
11,189
-12,641
-53% -$64.2K ﹤0.01% 2544
2024
Q1 		$101K Sell
23,830
-11,524
-33% -$40K ﹤0.01% 2337
2023
Q4 		$133K Buy
35,354
+19,769
+127% +$68K ﹤0.01% 2261
2023
Q3 		$57.7K Buy
+15,585
New +$62K ﹤0.01% 2276
2020
Q1 		– Sell
-14,978
Closed -$109K – 2062
2019
Q4 		$109K Sell
14,978
-8,046
-35% -$49.2K ﹤0.01% 2074
2019
Q3 		$147K Buy
+23,024
New +$193K ﹤0.01% 2052
2016
Q2 		– Sell
-13,762
Closed -$182K – 2208
2016
Q1 		$182K Sell
13,762
-50,281
-79% -$488K ﹤0.01% 2125
2015
Q4 		$650K Sell
64,043
-16,430
-20% -$189K ﹤0.01% 1761
2015
Q3 		$801K Buy
80,473
+56,664
+238% +$874K ﹤0.01% 1545
2015
Q2 		$462K Buy
23,809
+21,289
+845% +$730K ﹤0.01% 1820
2015
Q1 		$124K Buy
+2,520
New +$59.8K ﹤0.01% 2062
2013
Q3 		– Sell
-12,518
Closed -$59K – 2487
2013
Q2 		$59K Buy
+12,518
New +$45.2K ﹤0.01% 2309

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cliff Asness's CRMD Position: Q2 2026 in Review

Cliff Asness reduced its CorMedix (CRMD) stake by 35% in Q2 2026, selling an estimated $658K and leaving 151,435 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Cliff Asness first reported a position in CRMD in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.79M in Q4 2025. 192 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Cliff Asness held 151,435 shares of CorMedix worth $1.19M as of Q2 2026.
  • Cliff Asness sold 83,249 CorMedix shares in Q2 2026, an estimated $658K.
  • CorMedix made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2909 holding.
  • Cliff Asness first reported a position in CorMedix in Q2 2013 and has held it in 19 quarters since.
  • Cliff Asness's CorMedix position peaked at $1.79M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.